Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
about
Nanosizing of drugs: Effect on dissolution rateZinc protoporphyrin polymeric nanoparticles: potent heme oxygenase inhibitor for cancer therapy.PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study.Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology.Rationally designed nanocarriers for intranasaltherapy of allergic rhinitis: influence of carrier type on in vivo nasal depositionDrug delivery implants in the treatment of vitreous inflammationComprehensive review on additives of topical dosage forms for drug delivery.Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration.Brain-targeted delivery of docetaxel by glutathione-coated nanoparticles for brain cancer.Monitoring model drug microencapsulation in PLGA scaffolds using X-ray powder diffraction.Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.Polymerization-Induced Phase Separation Formation of Structured Hydrogel Particles via Microfluidics for Scar Therapeutics.Management of chronic ocular sarcoidosis: challenges and solutions.Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization.Solid-state characterization of triamcinolone acetonide nanosuspensiones by X-ray spectroscopy, ATR Fourier transforms infrared spectroscopy and differential scanning calorimetry analysis.
P2860
Q26781058-8373AEE0-A66B-4E46-AEF7-9121C437DD14Q35099351-B9FFA77E-9C6C-4922-9FD4-98E55F99F323Q36070388-73B42026-C162-40D7-A4AD-AE81B68EF8C3Q36204438-60C98BBC-9D01-4DED-B162-132B4AD7D877Q36951485-2AFFC686-52FF-462A-9032-D00977809461Q38160003-56A95BE8-E438-44B4-A65B-5C00DD9890FBQ38181173-CA8F9694-0932-4AD3-8BD1-9E70C71BE0DAQ38953075-FF84FD2D-FA45-467D-87E5-7610841B14EBQ38964871-9F3F408A-1C16-4C1F-B67D-9D99C49C4494Q39021288-DD0E9423-A295-485C-B626-3B4D90E62334Q41545455-A06116F0-1C6D-420C-94BE-C1A81DD22850Q49358311-1B086EA6-2148-493B-8545-1321123DF3D9Q52338865-816381C4-9625-447F-AB5B-43582FFBC897Q53458423-683B4DAB-45D6-48F5-BAB0-E46B40223F15Q55179926-213BD804-C051-4603-9B2E-29D4CF5FD5CE
P2860
Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@ast
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@en
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@nl
type
label
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@ast
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@en
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@nl
prefLabel
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@ast
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@en
Polymeric triamcinolone aceton ...... in vitro and in vivo studies.
@nl
P2093
P1476
Polymeric triamcinolone aceton ...... : in vitro and in vivo studies
@en
P2093
Alireza Hedayatfar
Araz Sabzevari
Hassan Hashemi
Mohammad Hossein Ghahremani
Navid Mohsenzadeh
Rassoul Dinarvand
P356
10.1016/J.EJPB.2012.12.010
P407
P577
2013-01-05T00:00:00Z